Tobacco causes a staggering 50% of deaths in those who use it, yet there is evidence that behavioral health care professionals don’t do enough to intervene and provide treatment. Tobacco use rates, although declining in the general population, are still two to three times higher in individuals with a behavioral health condition (mental illness or addiction) and this group consumes at least a third of the tobacco sold in the United States. Tobacco use also negatively impacts recovery from other substances and leads to poorer health and mental health.
This presentation provides updates in treatment and review relevant issues related to poor outcomes including levels of nicotine dependence and lack of access to cessation treatments. It includes practical techniques for assessment as well as evidence based practices for counseling and pharmacotherapy. Techniques for working with lower motivated tobacco users are also reviewed.
FREE - $0
Funding for this initiative was made possible (in part) by Grant No. 1H79SM080818-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
- Summarize tobacco use co-occurrence with mental illness and other addictions including epidemiology and consequences of tobacco use
- Describe basic assessment and treatment of tobacco dependence including the use of pharmacotherapies and highlighting issues relevant to treatment of tobacco dependence in mental health and addictions populations
- Identify tobacco treatment for these groups and the need for development of services within the behavioral health treatment setting.
Counselor, psychiatrist, psychologist, physician (non-psychiatric), physician assistant, pharmacist, nurse/nurse practitioner, peer support/peer specialist
Estimated Time to Complete
Estimated Duration: 1.0 hour
Program Start Date: May 15, 2020
Program End Date: March 1, 2021
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit™, nursing continuing professional development pharmacology contact hours (NCPD, formerly CNE), CE credit for psychologists, or a certificate of participation may do so by completing all sections of the course, including the evaluation. A multiple choice quiz is provided based on the content. A passing score of 75% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians), NCPD certificate (nursing), CE certificate (psychologists), or certificate of participation (other professions) showing the completion date and hours earned.
Continuing Education Credit
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Psychiatric Association is approved by the American Psychological Association to sponsor continuing education for psychologists. The American Psychiatric Association maintains responsibility for this program and its content.
The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Faculty and Planner Disclosures
- Jill Williams, MD, is Professor of Psychiatry and Director of the Division of Addiction Psychiatry at the Rutgers University-Robert Wood Johnson Medical School. Dr. Williams' work has focused on addressing tobacco in individuals with mental illness or other addictions through treatment and systems interventions. She has developed training curricula for behavioral health professionals and manualized treatments for treating tobacco in mental health settings. Dr. Williams discloses grant/research funding from Pfizer.
- Teri Brister, PhD, LPC, National Alliance on Mental Illness. Reports no financial relationships with commercial interests.
- Amy N. Cohen, PhD, American Psychiatric Association. Reports no financial relationships with commercial interests.
- Tristan Gorrindo, MD, American Psychiatric Association. Reports no financial relationships with commercial interests.
- Donna Rolin, PhD, APRN, University of Texas at Austin. Reports no financial relationships with commercial interests.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.
Optimal System Configuration
- Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
- Operating System: Windows XP+ or Mac OS X 10.4+
- Flash Player: Adobe Flash Player 10.3+
- Internet Connection: 1 Mbps or higher
- Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
- Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content
For assistance: Contact firstname.lastname@example.org for questions about this course | Contact SMIadviserHelp@psych.org for technical assistance